Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
BURLINGTON, Mass., Oct. 23, 2017 -- Nuance Communications, Inc. (NASDAQ:NUAN) today announced it has filed a patent infringement lawsuit in the U.S. Federal District Court of Delaware against M*Modal. The lawsuit alleges that M*Modal products violate six Nuance patents related to speech recognition, computer-assisted physician documentation and transcription technology applied in the healthcare IT market. This lawsuit is based on U.S. Patent nos. 9,564,126; 8,117,034; 7,379,946; 6,999,933; 6,766,295; and 6,308,158.
“Nuance has invested significant human and financial resources in developing innovations and building an intellectual property portfolio that are important components of our strategy and integral to the success of our business,” said David Greenbaum, Vice President of Litigation & Intellectual Property, Nuance. “Our IP and technology assets favorably differentiate our voice- and AI-powered offerings in the healthcare industry. We take great pride in, and place significant value on, our patents and will protect our rights.”
Nuance Healthcare provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to spend more time caring for patients. Nuance healthcare’s award-winning solutions capture more than 300 million patient stories each year, delivering real-time clinical guidance at the point of decision making across the continuum of care. With deep partner integrations across the healthcare ecosystem and decades of clinical expertise, Nuance Healthcare provides a more complete and accurate view of patient care to improve the clinical and financial outcomes for more than 500,000 clinicians in 10,000 global healthcare organizations.
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ:NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit www.nuance.com.
Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
Media Contact:
Rick Mack
Nuance Communications, Inc.
Tel: (781) 565-5000
Email: [email protected]
